- "A little-noticed provision of the omnibus spending bill could give the agency power to ban off-label use of approved therapies."
- "Secreted within the 2023 omnibus appropriations bill—4,155 pages, spending $1.7 trillion—is a 19-line section that could change the way medicine is practiced."
The information is also covered in a substack by merylnass
- "The law that allowed for the use of off-label licensed drugs like HCQ and IVM appears to have been neutered. Also gone is the prohibition for using EUA products outside an emergency, discussed in a previous substack and confirmed by Sanjoy Mahajan’s identifying the FDA notice dated Jan. 31 that confirms it."
FDA drug section gets 75% of its income from Big Pharma - Oct 2022
More than half of the FDA entire budget now comes from Big Pharma, not the govt. – Sept 2018
America Desperately Needs a Much Better FDA - NYT Sept 2, 2021
NIH employees got 1.4 billion dollars in big-pharma royalties in 12 years - Jan 2023
New FDA head chosen because he had the fewest ties to big Pharma - Nov 2021